ROSENBLUM MARK J (Exec VP Finance, Interim CFO) received a stock award from DECOY THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/15/2023ACC: 0001615219-23-000025
Officer· Exec VP Finance, Interim CFO
Since Sep 2019
+6.43K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
6.43K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.43K
Price / share
—
Trade value
—
% of position
41.7%
2/13/2023
15.42K→21.85K
Total
Net shares
+6.43K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/13/2023 | A · Award | +6.43K | — | — | 41.7% | 15.42K | 21.85K |
| Total | +6.43K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported